about
Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status ConsiderationsFirst case of nontuberculous mycobacterial lung disease caused by Mycobacterium marseillense in a patient with systemic lupus erythematosus.Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients.Clinical demographics and outcomes in mechanically ventilated patients in Korean intensive care unitsResults of interventional bronchoscopy in the management of postoperative tracheobronchial stenosis.Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease.Performance evaluation of the Xpert MTB/RIF assay according to its clinical application.Development of a prediction rule for estimating postoperative pulmonary complications.Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis.Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.Chronic obstructive pulmonary disease severity is associated with severe pneumonia.Significance of myositis autoantibody in patients with idiopathic interstitial lung diseaseDifferences in clinical outcomes according to weaning classifications in medical intensive care unitsFactors that Predict Negative Results of QuantiFERON-TB Gold In-Tube Test in Patients with Culture-Confirmed Tuberculosis: A Multicenter Retrospective Cohort Study.Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of "Mycobacterium indicus pranii" genotypes in human lung infection.Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung DiseaseSerum Concentrations of Trace Elements in Patients with Tuberculosis and Its Association with Treatment Outcome.Association of ISMav6 with the Pattern of Antibiotic Resistance in Korean Mycobacterium avium Clinical Isolates but No Relevance between Their Genotypes and Clinical Features.Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case reportIsolated Endobronchial Mycobacterium avium Disease Associated with Lobar Atelectasis in an Immunocompetent Young Adult: A Case Report and Literature ReviewOutcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary AspergillosisTreatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary TuberculosisTreatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimenNontuberculous Mycobacterial Lung Disease Caused by Mycobacterium lentiflavum in a Patient with Bronchiectasis.Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosisPeak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung DiseaseRelationship Between Forced Vital Capacity and Framingham Cardiovascular Risk Score Beyond the Presence of Metabolic Syndrome: The Fourth Korea National Health and Nutrition Examination SurveyIncreasing Recovery of Nontuberculous Mycobacteria from Respiratory Specimens over a 10-Year Period in a Tertiary Referral Hospital in South Korea.Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.COPD assessment test score and serum C-reactive protein levels in stable COPD patients.The First Korean Case of Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium abscessus Subspecies bolletii in a Patient with Bronchiectasis.Tuberculosis: clinical trials and new drug regimens.Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resection.Functional status and mortality prediction in community-acquired pneumonia.Serum inflammatory profiles in pulmonary tuberculosis and their association with treatment response.The Utility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Patients with Small-cell Lung Cancer.Clinical significance of differentiating post-intubation and post-tracheostomy tracheal stenosis.
P50
Q28079207-E07773C1-CE74-467F-A793-B797A5AC2B12Q30809495-C64FA375-123A-4DF6-A28A-BCA368AD7734Q33434536-8FE8C606-34CF-41C7-9C0A-55C6ED463F16Q33749257-21089EAE-044C-4D5A-8574-CE61DDD8AB85Q34260636-20C43BF9-1C2D-4F8A-A409-7657D0B66642Q34308874-07AC2552-8B75-4695-B325-7C6791A4F170Q34584703-13C95393-1449-4644-A6E6-D0F73D153204Q34600047-D8DCDE0D-8E9D-4220-A0BF-36224A01513AQ34628792-E8EDB80E-9BFB-4AA2-9843-80BB45730939Q34923083-27133227-F58B-4936-8BED-A33ECB1D593BQ35127708-86F6E2CE-E2B0-40B3-83F5-A3D901F99438Q35154706-3A1A9B7E-0853-42FA-9415-AA31E0C4B0ABQ35222192-536AB09A-9DDF-496B-A4D6-0669F12C97C0Q35421571-9303E032-608B-442A-BDDC-E17B4A6E3641Q35431995-EC0C2188-8ED3-4DA1-BE02-90E1084E8D1BQ35662499-39D7FB30-EE47-45BE-91C4-91CD6506521CQ35793970-E02AAC23-E5DD-40E2-8EB5-9C4049BEE7BAQ35859886-C4AFB2D5-3881-453D-BC25-9E088B8F5E98Q35895118-05DF965A-FCB0-429D-9BD1-FDC03CFD3B52Q35918281-E20B74A0-E52A-4C09-825A-8385D66C76FBQ36020330-65E97CB2-6006-4EE8-B335-E625E7449EB5Q36205525-DC82A300-0532-44C8-9E88-AC7408487027Q36231838-290A20E4-2916-4E2F-8405-BD82C7AEE7F1Q36439006-36E28E8A-066B-4F1A-A83E-116B773FD29EQ36785858-5391685B-9AFC-446D-A477-0B3872EF1A0BQ36837411-080170DB-09C0-47D0-8C25-7C4605249C1DQ37165276-1359466E-F156-4493-9BD1-C0E967FABB3BQ37287653-887A8119-E3E1-4340-8781-D8911DD00357Q37328619-D5D16C37-1884-4382-BC68-430526809140Q37388390-775BF1C4-26FD-4298-8B33-ECE298AC9702Q37478874-20A78693-EBE5-4D90-B13F-24BF509523ECQ37496470-26B9CE86-A199-486C-B6EB-31978D8661EFQ37575194-2E879A4F-E713-4931-9DAD-3C0312B8C7A5Q38194854-C9685960-2CF7-4800-9476-C2F498639C81Q38261230-A8FDC8F0-67E2-4DDA-BB48-5926A9C5DB2DQ38399379-B23A0415-CCB8-40AD-AD97-790B93449F15Q38780796-1713DF9C-D860-441B-A917-9D7AF031F5CFQ38806517-35EC8757-D153-42B4-B128-F471DA4242CDQ38826996-EB00EF23-2DFA-4F8C-83C7-9045D5CA6147Q38987161-1D9EE6BB-47A8-408C-9890-11AC5BD1B162
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Byeong-Ho Jeong
@ast
Byeong-Ho Jeong
@en
Byeong-Ho Jeong
@es
Byeong-Ho Jeong
@nl
type
label
Byeong-Ho Jeong
@ast
Byeong-Ho Jeong
@en
Byeong-Ho Jeong
@es
Byeong-Ho Jeong
@nl
prefLabel
Byeong-Ho Jeong
@ast
Byeong-Ho Jeong
@en
Byeong-Ho Jeong
@es
Byeong-Ho Jeong
@nl
P106
P31
P496
0000-0002-3124-1718